Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON K7L 3N6, Canada.
Cancer Research Center of Lyon (CRCL), UMR Inserm 1052 CNRS 5286 Mixte CLB, Université de Lyon 1 (UCBL1), 69003 Lyon, France.
Int J Mol Sci. 2020 Mar 18;21(6):2091. doi: 10.3390/ijms21062091.
Hepatitis C virus (HCV) is a major cause of chronic hepatitis and liver disease worldwide. Its tissue and species tropism are largely defined by the viral entry process that is required for subsequent productive viral infection and establishment of chronic infection. This review provides an overview of the viral and host factors involved in HCV entry into hepatocytes, summarizes our understanding of the molecular mechanisms governing this process and highlights the therapeutic potential of host-targeting entry inhibitors.
丙型肝炎病毒(HCV)是全球范围内导致慢性肝炎和肝脏疾病的主要原因。其组织和物种嗜性在很大程度上由病毒进入过程决定,该过程是后续产生性病毒感染和慢性感染建立所必需的。本综述概述了参与 HCV 进入肝细胞的病毒和宿主因素,总结了我们对控制该过程的分子机制的理解,并强调了宿主靶向进入抑制剂的治疗潜力。